Clinical trial Recruiting at 1 site Observational Ages 0 Days to 100

Registry to learn about individuals with sex chromosome variations

Official title: Generating Advancements Through Longitudinal Analysis in X and Y Variations

Run by University of Colorado, Denver · NCT06373861 · Data updated 2026-11-12

This study is gathering information from people with sex chromosome variations, like Klinefelter syndrome, to better understand their health and improve their care.

Quick facts

Study typeObservational
Ages0 Days to 100 Years
SexAll
Enrollment5000 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Locations1 site (Aurora, Colorado)
StatusRecruiting
StartedApril 28, 2022
Main results expectedApril 2037
Study endsApril 2037
Registry record updatedApril 18, 2024
Trial IDNCT06373861 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals of any age and gender with a genetically-confirmed diagnosis of a sex chromosome aneuploidy.

Probably not a fit

Patients without documented genetic testing confirming their diagnosis of sex chromosome aneuploidy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

GALAXY is a registry that aims to gather extensive information on individuals with sex chromosome aneuploidies, such as Klinefelter syndrome and other X&Y variations. The study collects data from medical records, including genetic tests, imaging, and medications, from patients seen at various clinics across the United States. By compiling this information, the registry seeks to enhance understanding and improve health outcomes for those affected by these conditions.

Why it matters

Potential benefit: If successful, this study could lead to better health management and treatment strategies for individuals with sex chromosome aneuploidies.

How similar studies have gone: While this approach is observational and registry-based, similar studies have shown promise in improving understanding and treatment of genetic conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Genetically-confirmed diagnosis of a sex chromosome aneuploidy condition
2. Any age
3. Any gender
4. Informed consent for individuals \>18 years of age, parent/guardian permission for individuals \<18 or proxy-consent from legally authorized representative if impaired decision making

Exclusion Criteria:

a. Lack of documentation of genetic testing confirming SCA diagnosis

Where it's running

  • Children's Hospital Colorado
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.